Home › Funds › Shah Wealth Advisors, LLC › CRSP
Shah Wealth Advisors, LLC position in CRSP
CRISPR THERAPEUTICS AG NAMEN AKT · Health Care
Shah Wealth Advisors, LLC reported holding 111,328 shares of CRSP (CRISPR THERAPEUTICS AG NAMEN AKT) in its Q3 2026 13F filing — a position valued at US$6.2M, representing 1.22% of its reported portfolio and ranking #21 among its reported holdings. Shah Wealth Advisors, LLC has disclosed CRSP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How Shah Wealth Advisors, LLC's CRSP position evolved
Shah Wealth Advisors, LLC first disclosed a stake in CRSP in Q2 2026 at 69,060 shares (US$3.8M). The position peaked in Q3 2026 at 111,328 shares, worth US$6.2M. Across 2 filings, Shah Wealth Advisors, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 111,328 shares valued at US$6.2M — an increase of 42,268 shares quarter over quarter.. Notable position changes include a 61% increase in Q3 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 69.06K | $3.77M | New |
| Q3 2026 | 111.33K | $6.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRSP and 13F data
CRSP (CRISPR THERAPEUTICS AG NAMEN AKT) is a Health Care company. 32 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$144.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRSP
- ARK Invest 9.46M sh · $516.00M · Q2 2026
- Orbis Allan Gray Ltd 5.45M sh · $297.20M · Q2 2026
- GSK plc 2.61M sh · $144.30M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.04M sh · $111.19M · Q2 2026
- Amova Asset Management Americas, Inc. 1.72M sh · $93.76M · Q2 2026
- EcoR1 Capital, LLC 1.39M sh · $75.77M · Q2 2026
- NEA Management Company, LLC 1.06M sh · $57.73M · Q2 2026
More on Shah Wealth Advisors, LLC
FAQ
How long has Shah Wealth Advisors, LLC held CRSP?
Shah Wealth Advisors, LLC has disclosed CRSP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Shah Wealth Advisors, LLC's current position in CRSP?
As of Q3 2026, Shah Wealth Advisors, LLC holds 111.33K shares of CRSP (CRISPR THERAPEUTICS AG NAMEN AKT), valued at $6.16M, representing 1.22% of its reported portfolio and ranking #21.
Has Shah Wealth Advisors, LLC been buying or selling CRSP?
In the latest 13F filing (Q3 2026), Shah Wealth Advisors, LLC increased its position in CRSP. The position peaked in Q3 2026 at 111.33K shares.
Which other funds hold CRSP?
Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.